ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
81.40
-18.60
(-18.60%)
Closed December 22 4:00PM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
81.40
Bid
81.20
Ask
81.60
Volume
79,629
72.40 Day's Range 100.50
0.00 52 Week Range 0.00
Market Cap
Previous Close
100.00
Open
100.00
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
4,462,229,293
Dividend Yield
-
PE Ratio
4.52
Earnings Per Share (EPS)
18.75
Revenue
232.26B
Net Profit
83.68B

About Novo Nordisk

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Bagsvaerd, Dnk
Founded
-
Novo Nordisk is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOVA. The last closing price for Novo Nordisk was 100.00 €. Over the last year, Novo Nordisk shares have traded in a share price range of 0.00 € to 0.00 €.

Novo Nordisk currently has 4,462,229,293 shares outstanding. The market capitalization of Novo Nordisk is 446.22 € billion. Novo Nordisk has a price to earnings ratio (PE ratio) of 4.52.

NOVA Latest News

Success of the Simplified Cash Tender Offer for the Shares & bons de souscription d’actions of Novagali Pharma SA by Santen...

Regulatory News: Santen Pharmaceutical Co., Ltd. (“Santen”) and Novagali Pharma SA (“Novagali”) announced today the success of the simplified cash tender offer for the...

Novagali Pharma: Revenue for the 3rd quarter of 2011

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops and markets innovative ophthalmic products, today announces its revenue for the first...

Santen Pharmaceutical Co., Ltd. Completes the Acquisition of a Controlling Interest in Novagali Pharma S.A.

Regulatory News: Following the press release of September 28, 2011, in accordance with articles 223-2 and 223-6 of the general regulations of the French Autorité des...

Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.

Regulatory News: Santen Pharmaceutical Co., Ltd. (Osaka, Ticker Code 4536JP) (hereafter “Santen”), a leading Japanese pharmaceutical company, and Novagali Pharma S.A...

Novagali Pharma Reports Positive Results in Phase II Study for Catioprost® vs. Travatan Z® in Patients with Glaucoma & Ocul...

Regulatory News: Novagali Pharma (Paris:NOVA) announced today US phase II positive results on the efficacy and safety of Catioprost® in patients with glaucoma and...

Novagali: Availability of the 2011 half-year financial report

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops and markets innovative ophthalmic products, informs its shareholders and the financial...

Novagali: 2011 First-Half Results

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops and markets innovative ophthalmic products, today announces its half-year results1 to...

Novagali : Revenue for the first half of 2011

Regulatory News: Novagali (Paris:NOVA): Novagali Pharma, a pharmaceutical company that develops and sells innovative ophthalmic products, today announces its revenue for...

Novagali Pharma: Supervisory Board Strengthened Significantly

Regulatory News: Approval of all the resolutions proposed at the Combined General Meeting of the shareholders on June 22, 2011 Novagali Pharma (Paris:NOVA), a...

Novagali Pharma and Ardeo Sign an Exclusive Distribution Agreement for Nova23041 in the United States and Canada

Regulatory News: Novagali Pharma (Paris:NOVA), a pharmaceutical company that develops innovative ophthalmic products, can today announce that it has signed an exclusive...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

NOVA - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk share price?
The current share price of Novo Nordisk is 81.40 €
How many Novo Nordisk shares are in issue?
Novo Nordisk has 4,462,229,293 shares in issue
What is the market cap of Novo Nordisk?
The market capitalisation of Novo Nordisk is EUR 446.22B
What is the 1 year trading range for Novo Nordisk share price?
Novo Nordisk has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Novo Nordisk?
The price to earnings ratio of Novo Nordisk is 4.52
What is the cash to sales ratio of Novo Nordisk?
The cash to sales ratio of Novo Nordisk is 1.63
What is the reporting currency for Novo Nordisk?
Novo Nordisk reports financial results in DKK
What is the latest annual turnover for Novo Nordisk?
The latest annual turnover of Novo Nordisk is DKK 232.26B
What is the latest annual profit for Novo Nordisk?
The latest annual profit of Novo Nordisk is DKK 83.68B
What is the registered address of Novo Nordisk?
The registered address for Novo Nordisk is NOVO ALLE, BAGSVAERD, DK-2880
What is the Novo Nordisk website address?
The website address for Novo Nordisk is www.novonordisk.com
Which industry sector does Novo Nordisk operate in?
Novo Nordisk operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GX6TPI Composites Inc
2.258 €
(92.66%)
18.75k
LTIAptose Biosciences Inc
0.278 €
(68.48%)
430.65k
36GGBM Resources Limited
0.008 €
(60.00%)
102.8k
7ZGAskari Metals Ltd
0.0104 €
(48.57%)
155k
VOPInvestigator Resources Ltd
0.017 €
(47.83%)
23.1k
PHPNGalectin Therapeutics Inc
0.90 €
(-53.61%)
3.69k
AWY0Percheron Therapeutics Ltd
0.0025 €
(-44.44%)
658.15k
H5EHelma Eigenheimbau Ag
0.04 €
(-40.83%)
29.35k
7KOCullinan Metals Corp
0.0076 €
(-35.59%)
3.5k
W47Grid Battery Metals Inc
0.01 €
(-35.48%)
1,000
AXIAtos SE
0.0021 €
(0.00%)
474.93M
D7GNel ASA
0.253 €
(-0.16%)
4.33M
RQ0DWave Quantum Inc
6.38 €
(3.44%)
2.96M
R9BDeFi Technologies Inc
2.67 €
(10.56%)
2.3M
3CPXiaomi Corporation
3.886 €
(2.47%)
2.29M

Discussion

View Full Feed
KILLAZILLA KILLAZILLA 3 minutes ago
Shot caused MANY health problems to MANY people!!!!

Nobody could travel to or from Canada without their Gestapo "papers".

you're AN IDIOT for trying to defend that CRAP!!!

LOOK AT THE SCIENCE!!!

SHIT IS NOT A VACCINE!!!

FDA e
TLRY
SteveSchiets SteveSchiets 4 minutes ago
Chatpgt comment on the post. CUDA software could do thectrick for us. 



AMD
SteveSchiets SteveSchiets 6 minutes ago








SEV
capgain capgain 7 minutes ago
Commodity - Guthrie Trapp Trio - Tom Bukovac's Birthday Party - 12/20/2024

https://www.youtube.com/watch?v=DTvNeDQnTkc
Bull_Dolphin Bull_Dolphin 9 minutes ago
Press Stop, then use the arrow to advance one frame at a time. In the map legend it shows the time and date. The time is GMT, so subtract 6 hours for Eastern Standard Time..
The graphic shows the current fronts in the first frame, followed by 4 frames of the first day,(6 am, noon, 6 pm, mid
capgain capgain 9 minutes ago
Yes, it's worse than the media shows. Imagine that.
ElectricMountain53 ElectricMountain53 9 minutes ago
It's your own fault that I react in this way. On May 8th you received a friendly email from me with concerns I had about LW and especially Lebby's wordings after I went to YOUR meeting in Antwerp. You reacted very agressively without giving any answer and you told Jeunke to block me from the weekly
LWLG
brooklyn13 brooklyn13 12 minutes ago
Now show us a picture of your festive menorah.
tkg tkg 12 minutes ago
The optical transceiver market is 33 B in 2029, in this case it means 33/45 =0,733 or 73 % of $ 150 around $ 110 -120.
Oops little ( unbelievable big) difference.

I'm always so grateful for your valuable input jeunke22!
LWLG
capgain capgain 15 minutes ago
"TOO MANY COMMERCIALS, sheesh!" I agree.
chrismiss_everyday chrismiss_everyday 20 minutes ago
https://www.anavex.com/post/anavex-life-sciences-and-partex-group-announce-strategic-partnership

Jun 27, 2023

Anavex Life Sciences and Partex Group Announce Strategic Partnership to Leverage AI for Drug Development and Healthcare Sales Marketing Building a Patient-Centr
AVXL
copytele copytele 21 minutes ago
RGTI https://youtu.be/QmJGGNZ06RY
RGTI
capgain capgain 26 minutes ago
Look at you, nice Saturday.
copytele copytele 28 minutes ago
RGTI https://youtu.be/QmJGGNZ06RY
RGTI
borysek borysek 31 minutes ago
one good financial report can change a lot but it will never happen ... in the weed store close to my house called "The spirit Leaf " they stopped selling CGC products - NO DEMAND ...
WEED
Investor2014 Investor2014 33 minutes ago
Yeah and the $SAVA CEO according to you is and now was much better.
SAVA
ksquared ksquared 35 minutes ago
Thanks for the heads up, Bull.
I still haven't figured out how to pause the map and figure out the timing.
Good old (in)Accuweather predicts snow Tuesday morning.
It'll be warmer (high 39) so the paved surfaces should clear up nicely.
Alexulf Alexulf 37 minutes ago
Merry Christmas and Happy New Year! Let the peace in and recover to 2025,
we are in for big AITX things, see the website for full information;

https://aitx.ai/



GLTA
AITX
walterc walterc 39 minutes ago
for completness sake

you are one of these Belgians

and for your info.
i think you would be extremely happy with the profits made at lwlg even at these cratered prices.

so speak for yourself
LWLG
goldbarren58 goldbarren58 45 minutes ago
LOL Vic doesnt dirty his hands

he let Clayton or that navy guy do it
NWPN
Bull_Dolphin Bull_Dolphin 46 minutes ago
Good morning kk. Looks like your going to have a white Christmas:

https://www.wpc.ncep.noaa.gov/basicwx/day0-7loop.html
ElectricMountain53 ElectricMountain53 47 minutes ago
Doesn't take away the fact lots of belgians have invested in the worst performing stocks over the last decade. Niocorp, Lightwave to name a few LOL
LWLG
Frankestin Frankestin 53 minutes ago
Just think, in July, when was this offer closed, it was at 0.50 and there was no 74 day letter imminent!
TNXP